334 related articles for article (PubMed ID: 18219438)
1. Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2008 Feb; 82(2):92-101. PubMed ID: 18219438
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
4. Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures.
Verdel BM; Souverein PC; Egberts TC; van Staa TP; Leufkens HG; de Vries F
Bone; 2010 Sep; 47(3):604-9. PubMed ID: 20601295
[TBL] [Abstract][Full Text] [Related]
5. Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.
Vestergaard P; Prieto-Alhambra D; Javaid MK; Cooper C
Osteoporos Int; 2013 Feb; 24(2):671-80. PubMed ID: 22669469
[TBL] [Abstract][Full Text] [Related]
6. Antidepressants and the risk of falls among nursing home residents.
Thapa PB; Gideon P; Cost TW; Milam AB; Ray WA
N Engl J Med; 1998 Sep; 339(13):875-82. PubMed ID: 9744971
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
[TBL] [Abstract][Full Text] [Related]
8. Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication.
Tamblyn R; Bates DW; Buckeridge DL; Dixon WG; Girard N; Haas JS; Habib B; Iqbal U; Li J; Sheppard T
J Am Geriatr Soc; 2020 Jul; 68(7):1494-1503. PubMed ID: 32181493
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
Baumann P
Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture.
Vestergaard P; Rejnmark L; Mosekilde L
Osteoporos Int; 2006; 17(6):807-16. PubMed ID: 16520889
[TBL] [Abstract][Full Text] [Related]
11. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A.
Haduch A; Wójcikowski J; Daniel WA
Eur Neuropsychopharmacol; 2006 Apr; 16(3):178-86. PubMed ID: 16246530
[TBL] [Abstract][Full Text] [Related]
12. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
Schlienger RG; Fischer LM; Jick H; Meier CR
Drug Saf; 2004; 27(14):1157-65. PubMed ID: 15554748
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
[TBL] [Abstract][Full Text] [Related]
15. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction.
Sauer WH; Berlin JA; Kimmel SE
Circulation; 2003 Jul; 108(1):32-6. PubMed ID: 12821544
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database.
Coupland C; Hill T; Morriss R; Moore M; Arthur A; Hippisley-Cox J
BMC Med; 2018 Mar; 16(1):36. PubMed ID: 29514662
[TBL] [Abstract][Full Text] [Related]
17. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants.
Ginzburg R; Rosero E
Ann Pharmacother; 2009 Jan; 43(1):98-103. PubMed ID: 19116378
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study of selegiline-antidepressant drug interactions and a review of the literature.
Ritter JL; Alexander B
Ann Clin Psychiatry; 1997 Mar; 9(1):7-13. PubMed ID: 9167831
[TBL] [Abstract][Full Text] [Related]
19. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.
Nadgir SM; Malviya M
Neurochem Res; 2008 Nov; 33(11):2250-6. PubMed ID: 18437564
[TBL] [Abstract][Full Text] [Related]
20. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.
Liu B; Anderson G; Mittmann N; To T; Axcell T; Shear N
Lancet; 1998 May; 351(9112):1303-7. PubMed ID: 9643791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
